Predicting Activity Cliffs for Autonomous Medicinal Chemistry

The project addresses a critical bottleneck in drug discovery: Structure-Activity Relationship (SAR) discontinuity. While the concept of activity cliffs is well-established in chemoinformatics, this work scales the analysis to 25 million matched molecular pairs (MMP), aiming to provide a 'parsimonious' framework for autonomous drug design. The defensibility is currently low (3) because it is a very new research artifact (9 days old, 0 stars) with no established community or user base. The moat consists entirely of the methodology and the specific training/validation set derived from ChEMBL. Platform domination risk is high; specialized drug discovery platforms (Schrödinger, NVIDIA BioNeMo, Isomorphic Labs) are aggressively integrating SAR sensitivity tools. In the long term, frontier labs building multi-modal foundation models for chemistry (e.g., Google DeepMind's AlphaFold 3 or newer chemical LLMs) will likely internalize 'activity cliff' awareness as a baseline capability rather than a standalone tool. Its primary value today is as a reference implementation for autonomous synthesis loops.